Schroders Capital Global Innovation Trust makes investment in Memo Therapeutics
LONDON: Schroders Capital Global Innovation Trust has made a commitment of CHF 0.9 million (£0.8 million) to Memo Therapeutics AG, a Switzerland-based clinical-stage biopharmaceutical company....
Launching A Safe Pharmaceutical Product: Key Things To Consider
The pharmaceutical industry operates at the intersection of innovation and patient welfare. While introducing new medical solutions into the market is crucial, ensuring the safety...
Should You Consider A Career In The Pharmaceutical Sector?
Are you considering a career in the pharmaceutical industry? Maybe you’re someone looking for a job that has great monetary rewards, or perhaps one with...
Telix Pharmaceuticals acquires Optimal Tracers
MELBOURNE, AUSTRALIA: Telix Pharmaceuticals has entered into an agreement with Sacramento-based Northern California PET Imaging Center (NCPIC) to acquire Optimal Tracers. The acquisition of Optimal Tracers...
AstraZeneca signs multi-billion dollar deal with Ionis Pharmaceuticals
LONDON, UK: AstraZeneca has closed a global development and commercialisation agreement with Ionis Pharmaceuticals, Inc. (Ionis) for eplontersen, formerly known as IONIS-TTR-L. The companies will jointly develop and...
Hikma Pharmaceutical agrees to buy Custopharm for $375 million
Hikma Pharmaceutical , Custopharm , acquire, Waster Street Healthcare Partners, LONDON, UK: Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company and one of the largest suppliers of...
Clinigen Group partners with Eyevance Pharmaceuticals
LONDON, UK: Clinigen Group plc has signed an exclusive agreement to partner with Eyevance Pharmaceuticals, a wholly-owned subsidiary of Santen Pharmaceutical Co., LTD, to manage...
ViiV Healthcare and Halozyme enter global collaboration and license agreement for HIV medicine
LONDON, UK: Halozyme‘s drug delivery technology provides the opportunity to administer large volume subcutaneous injections that may enable dosing intervals of every three months and...
Phytocannabinoid medicine company, MGC Pharmaceuticals to list on LSE
LONDON: MGC Pharmaceuticals, a European based and Australian listed bio-pharma company, is in the final stages of listing the Company’s shares on the Standard Segment...
AstraZeneca signs definitive agreement to acquire Alexion Pharmaceuticals
CAMBRIDGE: AstraZeneca and Alexion Pharmaceuticals Inc. have entered into a definitive agreement for AstraZeneca to acquire Alexion, a news release said. Alexion shareholders will receive...
Open Orphan gets £4.3 million challenge study contract win with global vaccine company
LONDON: Open Orphan plc (ORPH), announced a new £4.3 million contract to conduct a human viral challenge study utilising one of its 8 traditional challenge...
FCA sets out approach on listings of cannabis-related companies in UK
LONDON: The UK Financial Conduct Authority (FCA) has explained its approach to assessing the applications from cannabis-related companies interested in listing in the UK. This...